203 related articles for article (PubMed ID: 30111327)
1. Beyond cure: patient reported outcomes of hepatitis C treatment among people who inject drugs in Australia.
Madden A; Hopwood M; Neale J; Treloar C
Harm Reduct J; 2018 Aug; 15(1):42. PubMed ID: 30111327
[TBL] [Abstract][Full Text] [Related]
2. Barriers to hepatitis C treatment among secondary needle and syringe program clients and opportunities to intervene.
Gunn J; McNally S; Ryan J; Layton C; Bryant M; Walker S; O'Mahony C; Pedrana A
Int J Drug Policy; 2021 Oct; 96():103387. PubMed ID: 34330571
[TBL] [Abstract][Full Text] [Related]
3. Injecting risk behaviours following treatment for hepatitis C virus infection among people who inject drugs: The Australian Trial in Acute Hepatitis C.
Alavi M; Spelman T; Matthews GV; Haber PS; Day C; van Beek I; Walsh N; Yeung B; Bruneau J; Petoumenos K; Dolan K; Kaldor JM; Dore GJ; Hellard M; Grebely J;
Int J Drug Policy; 2015 Oct; 26(10):976-83. PubMed ID: 26115881
[TBL] [Abstract][Full Text] [Related]
4. Changes in risk behaviours during and following treatment for hepatitis C virus infection among people who inject drugs: The ACTIVATE study.
Midgard H; Hajarizadeh B; Cunningham EB; Conway B; Backmund M; Bruggmann P; Bruneau J; Bourgeois S; Dunlop A; Foster GR; Hellard M; Robaeys G; Thurnheer MC; Weltman M; Amin J; Marks PS; Quiene S; Dore GJ; Dalgard O; Grebely J;
Int J Drug Policy; 2017 Sep; 47():230-238. PubMed ID: 28633998
[TBL] [Abstract][Full Text] [Related]
5. Health-related quality of life in active injecting drug users with and without chronic hepatitis C virus infection.
Dalgard O; Egeland A; Skaug K; Vilimas K; Steen T
Hepatology; 2004 Jan; 39(1):74-80. PubMed ID: 14752825
[TBL] [Abstract][Full Text] [Related]
6. Perceptions and concerns of hepatitis C reinfection following prison-wide treatment scale-up: Counterpublic health amid hepatitis C treatment as prevention efforts in the prison setting.
Lafferty L; Rance J; Grebely J; Dore GJ; Lloyd AR; Treloar C;
Int J Drug Policy; 2020 Mar; 77():102693. PubMed ID: 32045828
[TBL] [Abstract][Full Text] [Related]
7. Understanding decisions made about hepatitis C treatment by couples who inject drugs.
Treloar C; Rance J; Bryant J; Fraser S
J Viral Hepat; 2016 Feb; 23(2):89-95. PubMed ID: 26305873
[TBL] [Abstract][Full Text] [Related]
8. Treatment for hepatitis C virus infection among people who inject drugs attending opioid substitution treatment and community health clinics: the ETHOS Study.
Grebely J; Alavi M; Micallef M; Dunlop AJ; Balcomb AC; Phung N; Weltman MD; Day CA; Treloar C; Bath N; Haber PS; Dore GJ;
Addiction; 2016 Feb; 111(2):311-9. PubMed ID: 26451534
[TBL] [Abstract][Full Text] [Related]
9. 'Beyond the willing & the waiting' - The role of peer-based approaches in hepatitis C diagnosis & treatment.
Henderson C; Madden A; Kelsall J
Int J Drug Policy; 2017 Dec; 50():111-115. PubMed ID: 28927831
[TBL] [Abstract][Full Text] [Related]
10. Positive health beliefs and behaviours in the midst of difficult lives: women who inject drugs.
Olsen A; Banwell C; Dance P; Maher L
Int J Drug Policy; 2012 Jul; 23(4):312-8. PubMed ID: 22721571
[TBL] [Abstract][Full Text] [Related]
11. Does informing people who inject drugs of their hepatitis C status influence their injecting behaviour? Analysis of the Networks II study.
Aspinall EJ; Weir A; Sacks-Davis R; Spelman T; Grebely J; Higgs P; Hutchinson SJ; Hellard ME
Int J Drug Policy; 2014 Jan; 25(1):179-82. PubMed ID: 24315504
[TBL] [Abstract][Full Text] [Related]
12. "Eyes Wide Shut": narratives of women living with hepatitis C in Australia.
Crockett B; Gifford SM
Women Health; 2004; 39(4):117-37. PubMed ID: 15691088
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of response-guided directly observed pegylated interferon and self-administered ribavirin for people who inject drugs with hepatitis C virus genotype 2/3 infection: The ACTIVATE study.
Grebely J; Dalgard O; Cunningham EB; Hajarizadeh B; Foster GR; Bruggmann P; Conway B; Backmund M; Robaeys G; Swan T; Amin J; Marks PS; Quiene S; Applegate TL; Weltman M; Shaw D; Dunlop A; Hellard M; Bruneau J; Midgard H; Bourgeois S; Staehelin C; Dore GJ;
Int J Drug Policy; 2017 Sep; 47():177-186. PubMed ID: 28624134
[TBL] [Abstract][Full Text] [Related]
14. Determinants of hepatitis C antiviral effectiveness awareness among people who inject drugs in the direct-acting antiviral era.
Valerio H; McAuley A; Innes H; Palmateer N; Goldberg DJ; Munro A; Taylor A; Hutchinson SJ
Int J Drug Policy; 2018 Feb; 52():115-122. PubMed ID: 29414462
[TBL] [Abstract][Full Text] [Related]
15. Burden of hepatitis C virus disease and access to hepatitis C virus services in people who inject drugs in India: a cross-sectional study.
Solomon SS; Mehta SH; Srikrishnan AK; Solomon S; McFall AM; Laeyendecker O; Celentano DD; Iqbal SH; Anand S; Vasudevan CK; Saravanan S; Lucas GM; Kumar MS; Sulkowski MS; Quinn TC
Lancet Infect Dis; 2015 Jan; 15(1):36-45. PubMed ID: 25486851
[TBL] [Abstract][Full Text] [Related]
16. Beyond clinical outcomes: the social and healthcare system implications of hepatitis C treatment.
Torrens M; Soyemi T; Bowman D; Schatz E
BMC Infect Dis; 2020 Sep; 20(1):702. PubMed ID: 32972393
[TBL] [Abstract][Full Text] [Related]
17. The effect of social functioning and living arrangement on treatment intent, specialist assessment and treatment uptake for hepatitis C virus infection among people with a history of injecting drug use: The ETHOS study.
Fortier E; Alavi M; Micallef M; Dunlop AJ; Balcomb AC; Day CA; Treloar C; Bath N; Haber PS; Dore GJ; Bruneau J; Grebely J;
Int J Drug Policy; 2015 Nov; 26(11):1094-102. PubMed ID: 26145482
[TBL] [Abstract][Full Text] [Related]
18. Chronic hepatitis C and individuals with a history of injecting drugs in Spain: population assessment, challenges for successful treatment.
Roncero C; Littlewood R; Vega P; Martinez-Raga J; Torrens M
Eur J Gastroenterol Hepatol; 2017 Jun; 29(6):629-633. PubMed ID: 28230562
[TBL] [Abstract][Full Text] [Related]
19. Improving Screening Methods for Hepatitis C Among People Who Inject Drugs: Findings from the HepTLC Initiative, 2012-2014.
Blackburn NA; Patel RC; Zibbell JE
Public Health Rep; 2016; 131 Suppl 2(Suppl 2):91-7. PubMed ID: 27168667
[TBL] [Abstract][Full Text] [Related]
20. Discrimination by health care workers versus discrimination by others: countervailing forces on HCV treatment intentions.
Brener L; Horwitz R; von Hippel C; Bryant J; Treloar C
Psychol Health Med; 2015; 20(2):148-53. PubMed ID: 24889417
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
